EPISODE · Aug 29, 2022 · 11 MIN
Strategies to Guide Treatment Selection in Relapsed/Refractory AML: An Expert Discussion
from PeerVoice Clinical Pharmacology Video · host PeerVoice
Strategies to Guide Treatment Selection in Relapsed/Refractory AML: An Expert Discussion
Embed this episode
What this episode covers
Visit https://www.peervoice.com/RHQ860 to view the entire programme with slides. After completing “Strategies to Guide Treatment Selection in Relapsed/Refractory AML: An Expert Discussion”, participants will be able to: Summarize the clinical evidence with the latest targeted therapies available for the treatment of relapsed/refractory acute myeloid leukemia (R/R AML); and Apply best practices to optimize the selection of targeted therapy in the treatment of R/R AML.
Ready to play
Strategies to Guide Treatment Selection in Relapsed/Refractory AML: An Expert Discussion
No transcript for this episode yet
Similar Episodes
No similar episodes found.